Indeed, polymorphisms in (the promoter region of) TNFSF1B were associated with increased susceptibility for patients to develop RA, IBD or lupus, suggesting that TNFR2 mutations could lead to increased inflammation due to defective control mechanisms [111,112]. This evidence concerns the gene TNFRSF1B and rheumatoid arthritis.